Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» Oncovex
Oncovex
Top 10 late-stage cancer drugs in 2012
Top 10 late-stage cancer drugs in 2012
Fierce Biotech
BB1608
Boston Biomedical
Dainippon Sumitomo
cabozantinib
Exelixis
ONYX Pharmaceuticals
Carfilzomib
Medivation
Astellas
Enzalutamide
Ariad Pharmaceuticals
Ponatinib
Bayer
regorafenib
Oncovex
Amgen
Roche
Genentech
T-DM1
Immunogen
Aveo
tivozanib
Zaltrap
Sanofi
Regeneron
Flag link:
10 promising late-stage cancer drugs
10 promising late-stage cancer drugs
Fierce Biotech
cancer
Carfilzomib
crizotinib
vismodegib
Oncovex
PLX4032
Ponatinib
SGN-35
tivozanib
T-DM1
cabozantinib
ONYX Pharmaceuticals
Pfizer
Genentech
Curis
Amgen
Plexxikon
Seattle Genetics
Ariad Pharmaceuticals
Aveo Pharmaceutical
Exelixis
Roche
Flag link:
Amgen to Buy Cancer Drugmaker Biovex for $425 Million
Amgen to Buy Cancer Drugmaker Biovex for $425 Million
Bloomberg
BioVex
Amgen
M&A
Oncovex
Flag link:
